Audit Comp | Alchemix V3-logo

Audit Comp | Alchemix V3

|

Alchemix is your unified platform for saving, earning, borrowing, and fixed-term fixed-yield opportunities—all in one place. Built on years of iteration since launching the original self-repaying loan in 2021, Alchemix v3 brings all three pillars together with a smarter, more flexible design.

Status

Finished
Primary Pool
$70,000
All Stars Pool
$20,000
Podium Pool
$10,000
Start Date
14 October 2025
End Date
04 November 2025
Rewards Token
USDC
Lines of Code
2,612
  • Triaged by Immunefi

  • Runnable PoC Required

  • Vault program

This Audit Competition Is Over

Thank You to All Participating Security Researchers!

Your valuable contributions played a crucial role in identifying and resolving critical vulnerabilities, helping to strengthen and secure the platform for all users.

Start Date
14 October 2025 15:00 UTC
End Date
04 November 2025 14:00 UTC

VaultImmunefi vault program

Funds available

$0

30d Avg. Funds availability

$32.99

Assets in vault

    Public vault address

    0x5Ca183bD1F5129f189F6a0A1bB0BA05890243462

    Rewards

    Audit Comp | Alchemix V3 provides rewards in USDC on Optimism , denominated in USD.

    Rewards by Threat Level

    Smart Contract
    Critical
    Portion of Reward Pool
    High
    Portion of Reward Pool
    Medium
    Portion of Reward Pool
    Low
    Portion of Reward Pool
    All categories *
    Insight
    Portion of the Reward Pool
    Rewards Body

    Rewards are distributed among SRs according to Immunefi’s Standardized Competition Reward Terms and includes All Star Pool and Podium Pool reserved for All Star Program participants.

    Rewards are denominated in USD and distributed in USDC on Optimism

    The reward pool is $100,000 USD if any bug is found. That means that even if 1 Low severity bug is found, the whole reward pool is unlocked and has to be fully distributed between security researchers.

    If not a single bug is found (Insights do not count as bugs) the insight reward pool is $15,000 USD.

    Proof of Concept (PoC) Requirements A runnable PoC, demonstrating the bug's impact, is required for this program and has to comply with the Immunefi PoC Guidelines and Rules.

    Program Overview

    Alchemix is your unified platform for saving, earning, borrowing, and fixed-term fixed-yield opportunities—all in one place. Built on years of iteration since launching the original self-repaying loan in 2021, Alchemix v3 brings all three pillars together with a smarter, more flexible design. The protocol allows you to:

    • Save and grow – deposit ETH or USDC and let our vault invest and earn yield across diversified strategies.
    • Borrow up to 90% LTV – access liquidity now while your collateral grows with yield and your leverage is reduced over time through scheduled redemptions. No interest rates to monitor, no price-based liquidations.
    • Earn fixed-rate yield – lock in predictable returns through fixed-term redemptions of alETH or alUSD.

    There are a few elements to the system. First, there is the Meta Yield Token. This is a Morpho V2 vault with custom strategies and some custom admin roles. There is an ETH and a USDC vault for each chain.

    The core system is based around the Alchemist/Transmuter. Alchemists mint alAssets, and accept MYT as collatearl. Each Alchemist has a single alAsset it can mint (alETH for ETH, alUSD for USDC). Each Alchemist can only accept a single MYT token as collateral (MYT ETH for alETH Alchemist). Each Alchemist has a single Transmuter paired with it, and each Transmuter is only paired with a single Alchemist.

    The Transmuter’s role is to redeem alAssets. Users may deposit alAssets to the transmuter. After a fixed period of time, they may claim equivalent value (based on protocol assumption that 1 alAsset = 1 Underlying, ie 1 alETH = 1 ETH) of the MYT.

    The Alchemist’s role is to accept the MYT as collateral, mint alAsset debt, and fulfill redemption obligations to the transmuter. When a transmuter claim is executed, the Alchemist reduces global system debt, and sends MYT from the alchemist to the transmuter user. Thus, when a redemption occurs, an individual Alchemist position will see both their collateral and debt reduced.

    To ensure collateral will always be available for redemptions, the Alchemist employs an earmarking system. Essentially, the system will reserve collateral and debt from user positions for future transmuter claims (time-based, continuous). Earmarked collateral cannot be withdrawn from the system. The only way to withdraw earmarked collateral is to repay earmarked debt with external MYT tokens. Separately, non-earmarked collateral/debt may be repaid and/or withdrawn at any time (subject to LTV requirements).

    The MYT strategies are meant to be priced based off of fundamental oracles, ie the backing of each strategy. This is meant to avoid unfair liquidations due to flash crashes. Additionally, the MYT is never unwrapped or wrapped with the Alchemist - this is why transmuter positions recieve MYT tokens at time of redemption, not underlying.

    The MYT strategies have a dual-unwrap approach through contracts and dexes. When a better outcome is gained through a dex (vs wrapping), a dex is used. For unwrapping, if the contract unwrap is unavailable (due to a queue), a dex is used. Thus, the MYT may be worth 1 ETH from the Alchemist point of view, even if the unwrap value at that exact instance is 0.99 (due to one of the strategies having a withdrawal queue). For this reason, long-tail risk strategies should not be used in the MYT.

    Audits

    Auditor
    All Audits
    Completed at
    30 September 2025

    Known Issues

    Category
    Smart Contract
    Description / Link
    Technically an individual could open numerous small positions at max LTV, hoping that they become eligible for liquidation so they can liquidate themselves and get paid from the feeVault for a net profit. However, the feeVault ONLY pays out when the alchemist is globally undercollateralized, NOT for liquidate individually undercollateralized positions when global collateralization is otherwise acceptable. This is an acceptable risk and therefore not considered in scope.
    Last Updated At
    13 October 2025

    KYC not required

    No KYC information is required for payout processing.

    Proof of Concept

    Proof of concept is always required for all severities.

    Responsible Publication

    Category 3: Approval Required

    Prohibited Activities

    Default prohibited activities
    • Any testing on mainnet or public testnet deployed code; all testing should be done on local-forks of either public testnet or mainnet
    • Any testing with pricing oracles or third-party smart contracts
    • Attempting phishing or other social engineering attacks against our employees and/or customers
    • Any testing with third-party systems and applications (e.g. browser extensions) as well as websites (e.g. SSO providers, advertising networks)
    • Any denial of service attacks that are executed against project assets
    • Automated testing of services that generates significant amounts of traffic
    • Public disclosure of an unpatched vulnerability in an embargoed bounty
    • Any other actions prohibited by the Immunefi Rules

    Feasibility Limitations

    The project may be receiving reports that are valid (the bug and attack vector are real) and cite assets and impacts that are in scope, but there may be obstacles or barriers to executing the attack in the real world. In other words, there is a question about how feasible the attack really is. Conversely, there may also be mitigation measures that projects can take to prevent the impact of the bug, which are not feasible or would require unconventional action and hence, should not be used as reasons for downgrading a bug's severity.

    Therefore, Immunefi has developed a set of feasibility limitation standards which by default states what security researchers, as well as projects, can or cannot cite when reviewing a bug report.

    30d Avg. Funds Availability
    $32.99
    Total Assets in Scope
    28
    Audit Comp | Alchemix V3 Bug Bounties | Immunefi